NeoGenomics Inc (NEO)
14.28
+0.14
(+0.99%)
USD |
NASDAQ |
Nov 05, 11:47
NeoGenomics Gross Profit Margin (Quarterly): 44.07% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 44.07% |
| March 31, 2024 | 41.90% |
| December 31, 2023 | 43.45% |
| September 30, 2023 | 41.01% |
| June 30, 2023 | 40.77% |
| March 31, 2023 | 39.95% |
| December 31, 2022 | 40.97% |
| September 30, 2022 | 37.97% |
| June 30, 2022 | 35.14% |
| March 31, 2022 | 32.63% |
| December 31, 2021 | 35.99% |
| September 30, 2021 | 38.93% |
| June 30, 2021 | 43.53% |
| March 31, 2021 | 35.98% |
| December 31, 2020 | 45.60% |
| September 30, 2020 | 43.10% |
| June 30, 2020 | 32.20% |
| March 31, 2020 | 43.73% |
| December 31, 2019 | 46.71% |
| September 30, 2019 | 48.56% |
| June 30, 2019 | 48.14% |
| March 31, 2019 | 49.30% |
| December 31, 2018 | 48.53% |
| September 30, 2018 | 46.78% |
| June 30, 2018 | 45.07% |
| Date | Value |
|---|---|
| March 31, 2018 | 43.05% |
| December 31, 2017 | 43.57% |
| September 30, 2017 | 42.10% |
| June 30, 2017 | 43.93% |
| March 31, 2017 | 39.96% |
| December 31, 2016 | 31.07% |
| September 30, 2016 | 45.00% |
| June 30, 2016 | 45.31% |
| March 31, 2016 | 45.51% |
| December 31, 2015 | 44.83% |
| September 30, 2015 | 44.46% |
| June 30, 2015 | 44.37% |
| March 31, 2015 | 41.45% |
| December 31, 2014 | 45.88% |
| September 30, 2014 | 44.34% |
| June 30, 2014 | 49.54% |
| March 31, 2014 | 47.90% |
| December 31, 2013 | 50.01% |
| September 30, 2013 | 48.39% |
| June 30, 2013 | 45.87% |
| March 31, 2013 | 46.28% |
| December 31, 2012 | 43.20% |
| September 30, 2012 | 41.49% |
| June 30, 2012 | 47.19% |
| March 31, 2012 | 47.12% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
32.20%
Minimum
Jun 2020
46.71%
Maximum
Dec 2019
40.19%
Average
40.97%
Median
Dec 2022
Gross Profit Margin (Quarterly) Benchmarks
| Corcept Therapeutics Inc | 98.43% |
| Hologic Inc | 55.40% |
| Ekso Bionics Holdings Inc | 53.50% |
| T2 Biosystems Inc | -37.96% |
| CEL-SCI Corp | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -8.38% |
| Return on Assets | -4.71% |
| Return on Invested Capital | -5.32% |
| Profit Margin (Quarterly) | -11.33% |
| Operating Margin (Quarterly) | -12.40% |
| Return on Net Operating Assets | -6.26% |